Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop (2018)
Chapter: 4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier
Visit
NAP.edu/10766
to get more information about this book, to buy it in print, or to
download it as a free PDF.
Previous Chapter:
3 Modalities and Technologies for Brain Delivery
Next Chapter: 5 Accelerating Research and Clinical Translation: Consortia and Public–Private Partnerships
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
There was a problem loading page 25.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
There was a problem loading page 26.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
There was a problem loading page 27.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
There was a problem loading page 28.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
There was a problem loading page 29.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
There was a problem loading page 30.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
Suggested Citation:
"4 Regulatory Considerations for Drugs That Traverse the BloodBrain Barrier." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press.
doi: 10.17226/25044.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.